Cite

HARVARD Citation

    Shaw, P. et al. (2022). Tofersen in adults with SOD1-ALS: phase 3 VALOR trial and open-label extension results. Journal of neurology, neurosurgery and psychiatry. 93 (9), pp. e2-. [Online]. 
  
Back to record